Clinical trial
The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases
NCT01867281 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases
- Lead sponsor
- Tehran University of Medical Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- June 30, 2014
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.